Miami Breast Cancer Conference | Conferences

Healthcare Utilization and Costs Remain High for TNBC, Study Shows

March 12, 2017

According to a retrospective 4.5-year study of patients who had commercial and Medicare supplemental coverage, healthcare resource use and costs remain high among patients with metastatic triple-negative breast cancer.

PARP Inhibitors Likely This Year's Breakthrough In Breast Cancer Management

March 12, 2017

Kimberly Blackwell, MD, discusses the results of the recent phase III OLYMPIAD trial, which showed olaparib (Lynparza) improved progression-free survival (PFS) versus standard chemotherapy in patients with BRCA-positive breast cancer.

Incorporating Biologic Factors Into Breast Cancer Staging

March 12, 2017

Kelly K. Hunt, MD, professor of Surgery, and chair, Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, discusses incorporating biologic factors into breast cancer staging.

Targeting the Androgen Receptor in Breast Cancer

March 11, 2017

Hope Rugo, MD, a professor of Medicine and director of the Breast Oncology Clinical Trials Program at the UCSF Helen Diller Family Comprehensive Cancer Center, discusses targeting the androgen receptor in breast cancer.